| 000 | 03060cam0a2200577 4500 | ||
|---|---|---|---|
| 001 | 4022 | ||
| 009 | 013355155 | ||
| 003 | http://www.sudoc.fr/013355155 | ||
| 005 | 20250630091430.0 | ||
| 010 |
_a0824791916 _balk. paper |
||
| 020 |
_aUS _b944796 |
||
| 090 | _a4022 | ||
| 099 |
_tOUVR _zALEX16092 |
||
| 100 | _a19940621d1994 k y0frey50 ba | ||
| 101 | 0 |
_aeng _2639-2 |
|
| 102 | _aUS | ||
| 105 | _aa a 001yy | ||
| 106 | _ar | ||
| 181 |
_6z01 _ctxt _2rdacontent |
||
| 181 | 1 |
_6z01 _ai# _bxxxe## |
|
| 182 |
_6z01 _cn _2rdamedia |
||
| 182 | 1 |
_6z01 _an |
|
| 200 | 1 |
_aMultiparticulate oral drug delivery _fed. by Isaac Ghebre-Selassié |
|
| 210 |
_aNew York _aBasel _aHong Kong _cM. Dekker _d1994 |
||
| 215 |
_a1 vol. (viii-480 p.) _cill. _d24 cm |
||
| 225 | 1 |
_aDrugs and the pharmaceutical sciences _v65 |
|
| 320 | _aNotes bibliogr. Index | ||
| 327 | 1 |
_aManufacture of core pellets by balling / Lucy S.C. Wan _aPreparation of micropellets by spray congealing / A. Atilla Hincal, H. Suheyla Kas _aCryopelletization / Axel Knoch _aCoating of multiparticulates using polymeric solutions: formulation and process considerations / Klaus Lehmann _aCoating of multiparticulates using molten materials: formulation and process considerations / David M. Jones, Phillip J. Percel _aSuspensions and dispersible dosage forms of multiparticulates / Roland Bodmeier, Ornlaksana Paeratakul _aMultiparticulate encapsulation equipment and process / Donald K. Lightfoot _aCompaction of multiparticulate oral dosage forms / Metin Celik _aKey factors in the development of modified-release pellets / Stuart C. Porter, Isaac Ghebre-Sellassie _aMechanisms of release from coated pellets / Jennifer B. Dressman ... [et al.] _aBiopharmaceutical aspects of multiparticulates / Johannes Kramer, Henning Blume _aIn vivo behavior of multiparticulate versus single-unit dose formulations / George A. Digenis |
|
| 410 |
_0039504492 _tDrugs and the pharmaceutical sciences _x0360-2583 _v65 |
||
| 606 |
_3031778526 _aNanoparticules _3027790118 _xEmploi en thérapeutique _2rameau |
||
| 606 |
_3027239144 _aMédicaments _3027809633 _xAbsorption et adsorption _2rameau |
||
| 606 |
_3030011701 _aVoie orale _2rameau |
||
| 606 |
_3027502783 _aParticules (matière) _2rameau |
||
| 606 |
_aOral medication _2lc |
||
| 606 | 1 |
_aDosage Forms _2mesh |
|
| 606 | 2 |
_aDrug Delivery Systems _2mesh |
|
| 606 | 2 |
_aAdministration, Oral _2mesh |
|
| 606 | 2 |
_aDrug Design _2mesh |
|
| 606 |
_3040696413 _aFormes posologiques _2fmesh |
||
| 606 |
_3040813282 _aSystèmes de délivrance de médicaments _2fmesh |
||
| 606 |
_3040657272 _aAdministration par voie orale _2fmesh |
||
| 606 |
_3040802639 _aConception de médicament _2fmesh |
||
| 606 |
_aNanoparticles _2lc |
||
| 606 |
_aParticles _2lc |
||
| 606 |
_aDrugs _xDosage forms _2lc |
||
| 606 |
_3029722373 _aTechnologie pharmaceutique _2rameau |
||
| 676 |
_a615/.6 _v20 |
||
| 680 |
_aRS201.N35 _bM856 1994 |
||
| 686 |
_aW1 _bDR893B v.65 1994 _2usnlm |
||
| 686 |
_aQV 785 M961 1994 _2usnlm |
||
| 702 | 1 |
_3072286288 _aGhebre-Sellassie _bIsaac _f1947-.... _4340 |
|